Full Press Release Details
AI Announces Commercial Agreement with Top 5 Global Pharmaceutical Company to Identify and Prioritize Therapeutic Target in Major Depressive
agreement serves as high-profile third party validation of BullFrog AI's proprietary capabilities
utilizes BullFrog AI's end-to-end analytical AI platform to accelerate drug discovery and development program
Md., March 30, 2026 - BullFrog AI Holdings, Inc. (NASDAQ: BFRG; BFRGW) ("BullFrog AI" or the "Company"),
a technology company using artificial intelligence ("AI") and machine learning to turn complex biomedical data into actionable
insights, today announced a commercial agreement with a top 5 global pharmaceutical company in 2025 by revenue ("Customer"),
to apply the Company's proprietary bfLEAP platform to identify and prioritize novel drug targets in major depressive
disorder (MDD), accelerating the Customer's drug discovery and clinical development program for this indication. The agreement
also provides exclusive access to a target candidate. The MDD market was valued at more than $8 billion in 2025 and expected to grow
at an average annual rate of nearly 5% to reach in excess of $11 billion by 2032, according to Stellar Market Research.
agreement represents strong, high-quality validation of our proprietary capabilities from a leading industry partner, and we are confident
that this relationship will expand across other areas of the Customer's research and development portfolio," said BullFrog
AI Founder and CEO Vin Singh. "Our platform provides drug developers with an end-to-end analytical tool engineered to resolve multimodal
biological complexity at scale. Our bfLEAP , bfPREP , and bfARENASTM integrated platform leverages causal
network inference to provide drug developers a clearer path forward in the discovery and characterization of drug targets for complex
disease like MDD. We look forward to continuing to build on our successful record in identifying and prioritizing portfolios and expanding
our commercial partnerships."
details of the agreement may be found in BullFrog AI's Current Report on Form 8-K to be filed with the Securities and Exchange
Major Depressive Disorder (MDD)
depressive disorder (MDD) is diagnosed when an individual has a persistently low or depressed mood, anhedonia or decreased interest in
pleasurable activities, feelings of guilt or worthlessness, lack of energy, poor concentration, appetite changes, psychomotor retardation
or agitation, sleep disturbances, or suicidal thoughts. One of the main causes of disability in the world, MDD has been ranked as the
third cause of the burden of disease worldwide in 2008 by World Health Organization, which has projected that this disease will rank
AI leverages artificial intelligence and machine learning to advance drug discovery and development. Through collaborations with leading
research institutions, BullFrog AI uses causal AI in combination with its proprietary bfLEAP platform to analyze complex
biological data, aiming to streamline therapeutics development and reduce failure rates in clinical trials. For more information visit
BullFrog AI at: https://bullfrogai.com.
press release contains forward-looking statements. We base these forward-looking statements on our expectations and projections about
future events, which we derive from the information currently available to us. Such forward-looking statements relate to future events
or our future performance, including: our financial performance and projections; our revenue and earnings; and our business prospects
and opportunities. You can identify forward-looking statements by those that are not historical in nature, particularly those that use
terminology such as "may," "should," "could," "will," "expects," "anticipates,"
"contemplates," "estimates," "believes," "plans," "projected," "predicts,"
"potential," or "hopes" or the negative of these or similar terms. In evaluating these forward-looking statements,
you should consider various factors, including: our ability to change the direction of the Company; our ability to keep pace with new
technology and changing market needs; our and our partners' ability to market and sell our offerings and services, including BullFrog
Data Networks ; our ability to maintain compliance with Nasdaq listing rules; and the competitive environment of our business.
These and other factors may cause our actual results to differ materially from any forward-looking statement. Forward-looking statements
are only predictions. The forward-looking events discussed in this press release and other statements made from time to time by us or
our representatives, may not occur, and actual events and results may differ materially and are subject to risks, uncertainties, and
assumptions about us. We are not obligated to publicly update or revise any forward-looking statement, whether as a result of uncertainties
and assumptions, the forward-looking events discussed in this press release and other statements made from time to time by us or our
representatives might not occur.